Clinical Trial Update: Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This document reports the withdrawal of a Phase 1/2 trial evaluating a trivalent influenza vaccine combined with recombinant interferon alpha in people with chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Trivalent Influenza Vaccine with Recombinant Interferon Alpha (trivalent influenza vaccine with recombinant interferon alpha)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: WITHDRAWN